Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

4519

Rang în acțiuni #356
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Preț acțiune
$41.71
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$68.64B
Schimbare (1 zi)
2.01%
Schimbare (1 an)
-14.16%
Țară
JP
Tranzacționează Chugai Pharmaceutical Co., Ltd. (4519)

Categorie

Healthcare
Prețul 4519 cu capitalizarea de piață a B
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.
4519
$41.71
Capitalizarea de piață a Chugai Pharmaceutical Co., Ltd.(4519)
Capitalizare de piață: $68.64B
În anul October 2026, Chugai Pharmaceutical Co., Ltd. are o capitalizare de piață de $68.64B. Acest lucru face ca Chugai Pharmaceutical Co., Ltd. să fie a 356th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Chugai Pharmaceutical Co., Ltd. din 2000 până în 2026
4519 în comparație cu top 5 cele mai populare stocks
Prețul pentru 4519 Activul B Capitalizarea de piață a B Rezultate
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.
$3,139.60 $65.05B
$5.167T +7,843.33%
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.
$3,047.08 $65.05B
$5.015T +7,609.26%
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.
$2,496.35 $65.05B
$4.108T +6,215.88%
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.
$2,370.88 $65.05B
$3.902T +5,898.43%
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.
$1,634.17 $65.05B
$2.689T +4,034.52%